Why the study?
Do electronic medical record drug-targeted alerts improve clinical outcomes and reduce inappropriate prescribing in patients at risk of or with existing AKI?
Do electronic medical record drug-targeted alerts improve clinical outcomes and reduce inappropriate prescribing in patients at risk of or with existing AKI?
While EMR alerts for nephrotoxic drugs reduce inappropriate prescribing, their direct impact on patient clinical outcomes remains understudied.
Alerts reduce inappropriate prescribing; leaves open whether they improve clinical outcomes in AKI.
Nephrotoxin-induced AKI is an iatrogenic form of AKI that can be potentially avoided or ameliorated by prompt recognition and appropriate prescriber actions. Drug-targeted alerts, either for patients at risk of AKI or patients with existing AKI, may lead to more appropriate drug dosing and management and improved clinical outcomes. However, alerts of this type are complicated to create, have a high potential for error and off-target effects, and may be difficult to evaluate. Although many studies have shown that these alerts can reduce the rate of inappropriate prescribing, few studies have examined the utility of such alerts in terms of patient benefit. In this review, we examine the current state of the literature in this area, identify key technical challenges, and suggest methods of evaluation for drug-targeted AKI alerts.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: